Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual disease.

Journal of clinical pathology - 1 Jan 1996

Macedo A, San Miguel J F, Vidriales M B, López-Berges M C, García-Marcos M A, Gonzalez M, Landolfi C, Orfão A

Abstract excerpt

AIM: To explore the role of phenotypic changes as possible limiting factors in the immunological detection of minimal residual disease in patients with acute myeloid leukaemia (AML). METHODS: 20 relapses were evaluated, with special attention to changes in the criteria used for the definition of a phenotype as "aberrant". In all cases the same monoclonal antibody and fluorochrome were used at diagnosis and in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to Antigens, CD

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunophenotyping

Share to Leukemia, Myeloid

Share to Phenotype

Share to Recurrence

Source

Open in PubMed Open full text

Identifiers

PMID: 8666678
DOI: 10.1136/jcp.49.1.15
PMCID: PMC1023150

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual disease.PMID 8666678Read ↗

Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies.Semantic proximity Read ↗

Characterization of aberrant phenotypes in acute myeloblastic leukemia.Semantic proximity Read ↗

Stability of leukemia‐associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: Comparison with cytomorphologic, cytogenetic, and molecular genetic findingsSemantic proximity Read ↗

Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoringSemantic proximity Read ↗

Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.Semantic proximity Read ↗

Detection of minimal residual disease in acute myelogenous leukemia.Semantic proximity Read ↗

Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.Semantic proximity Read ↗

Leukaemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcome.Semantic proximity Read ↗

Detection of minimal residual disease in leukemias: a critical approach.Semantic proximity Read ↗

The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.Semantic proximity Read ↗

[Minimal residual disease in acute lymphoblastic leukemia: a new concept of complete remission].Semantic proximity Read ↗

The immunologic detection of minimal residual disease in acute leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.